A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PF / plus 5-fluorouracil

[Related PubMed/MEDLINE]
Total Number of Papers: 12
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PF  (>> Co-occurring Abbreviation)
Long Form:   plus 5-fluorouracil
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study. IMRT, NPC, NTZ, RR
2019 Laryngeal Preservation Strategies in Locally Advanced Laryngeal and Hypopharyngeal Cancers. chemoRT, LP, RT, SCC, TL
2018 The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era. AJCC, CCRT, DMFS, ICRT, IMRT, LRFFS, NPC, OS, PFS
2017 Chemotherapy regimens containing taxanes or fluorouracil in nasopharyngeal carcinoma: Which better? DFS, DMFS, LRRFS, NPC, OS, TP
2015 Taxane-cisplatin-fluorouracil as induction chemotherapy for advanced head and neck cancer: a meta-analysis of the 5-year efficacy and safety. ORR, OS, PFS
2013 Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. HR, IPD, LAHNCs
2013 Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern. CCRT, CR, OS, SCC
2008 [Phase II clinical trial of concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil) for esophageal cancer]. CRT, ESCC, LCAF
2006 Treatment of Stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes. NPC, PG
10  2004 [Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus]. AF
11  1998 erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. CI, DDFS, DFS, PAF, RFS, RR
12  1990 Evaluation of the worth of corynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer. Eight-year results from the National Surgical Adjuvant Breast and Bowel Project B-10. DFS, L-PAM, NSABP